Athena Pelvic Muscle Trainer - DUETS Trial (DUETS)

July 13, 2011 updated by: Athena Feminine Technologies, Inc.

Athena PMT - Device to Treat Urinary Incontinence - Effectiveness, Tolerability and Satisfaction "Athena D.U.E.T.S. Trial"

The purpose of this study is to determine if the Athena Pelvic Muscle Trainer device effectively treats stress, urge or mixed incontinence in women by strengthening the pelvic floor muscles by collecting data from the patient on the

  1. Over Active Bladder Questionnaire
  2. The 7-Day Urine Diary questionnaire

    This study will also look at whether or not there is an improvement in sexual health after using the device by collecting data frm the patient on the

  3. Female Sexual Function Index questionnaire

Study Overview

Status

Completed

Detailed Description

This is a Phase IV, prospective, open-label, multi-center, observational study to assess the effectiveness of the Athena PMT to relieve or eliminate the symptoms of female urinary incontinence.

The study will enlist approximately 100 or more Nurse-Practitioners in Women's Health as the principle investigators from community-based primary care centers (OB-GYN, Internal Medicine, Family Practices or Women's Health Centers) who will enroll approximately 500 or more subjects who suffer from urge and/or stress urinary incontinence and who may benefit from strengthening of Kegel muscles of the pelvic floor.

Study Type

Interventional

Enrollment (Actual)

462

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alabama
      • Birmingham, Alabama, United States, 35205
        • John Foster MD
      • Birmingham, Alabama, United States, 35211
        • La Mamma Spa
      • Dothan, Alabama, United States, 36305
        • Kyle Chavers MD
    • Arizona
      • Casa Grande, Arizona, United States, 85122
        • Salud! for Women
      • Chandler, Arizona, United States, 85226
        • New Horizons Women's Care
      • Peoria, Arizona, United States, 85381
        • Barbara Wiggin PhD, ANP-C
      • Phoenix, Arizona, United States, 85044
        • Agnes Oblas APRN
      • Scottsdale, Arizona, United States, 85251
        • Arcadia Well Woman
      • Tempe, Arizona, United States, 85283
        • Patricia A Faust
      • Tucson, Arizona, United States, 85704
        • Beth Andresen
      • Tucson, Arizona, United States, 85704
        • Teresa Mote RNC NP
    • California
      • El Dorado Hills, California, United States, 95726
        • Brenda Hanson-Smith, RN, DNS, OGNP
      • Ontario, California, United States, 91762
        • Lynda Reed
      • Rolling Hills Est., California, United States, 90274
        • Rose Mary Mosher
      • San Diego, California, United States, 92103
        • Evan Vapnek MD
      • San Jacinto, California, United States, 92583
        • Marilyn Brooks
      • San Luis Obispo, California, United States, 93405
        • Healthworks
    • Colorado
      • Northglenn, Colorado, United States, 80234
        • Maureen Allen
      • Parker, Colorado, United States, 80134
        • Kristan Langdon, ANP-C
      • Salida, Colorado, United States, 81201
        • Karen D. Adamson
    • Connecticut
      • New London, Connecticut, United States, 06320
        • Merrilyn H. McNatt APRN
      • South Windsor, Connecticut, United States, 06074
        • Jean Ohliger APRN
    • Florida
      • Blountstown, Florida, United States, 32424
        • Arlena Falcon
      • Boynton Beach, Florida, United States, 33472
        • Carl Spirazza
      • Ft. Lauderdale, Florida, United States, 33316
        • Khadra Mohamoud Osman mD
      • Lake Worth, Florida, United States, 33461
        • Shelly E Kramer ARNP
      • Margate, Florida, United States, 33316
        • Ivonne M. Reynolds
      • Ormond Beach, Florida, United States, 32174
        • Susan Chappuis, ARNP-C
      • Stuart, Florida, United States, 34994
        • Elizabeth Tsarnas
      • Venice, Florida, United States, 34285
        • Bayside Gynecology, P.A.
      • West Palm Beach, Florida, United States, 33407
        • Jeffrey C Seiler, MD
    • Georgia
      • Albany, Georgia, United States, 31707
        • Deborah Cothran WHNP-BC
      • Fayetteville, Georgia, United States, 30214
        • Elizabeth Killebrew MD
    • Illinois
      • DeKalb, Illinois, United States, 60115
        • Laurie Knoke
      • Deerfield, Illinois, United States, 60015
        • Michael D Benson
      • Gurnee, Illinois, United States, 60031
        • Sherry Owen, APN
      • Park Ridge, Illinois, United States, 60068
        • Julie Snow
    • Indiana
      • Carmel, Indiana, United States, 46032
        • Kathryn A. Copeland
      • Fort Wayne, Indiana, United States, 46825
        • Matthew Sprunger MD
    • Kansas
      • Lakin, Kansas, United States, 67860
        • Tamara Meisel ARNP
    • Kentucky
      • Ashland, Kentucky, United States, 41105
        • Richard F. Ford MD
      • Lexington, Kentucky, United States, 40503
        • Women's Care Center
    • Louisiana
      • Bossier City, Louisiana, United States, 71111
        • Tammi K Herkey
      • Covington, Louisiana, United States, 70433
        • Stefanie A Schultis
    • Maryland
      • Bel Air, Maryland, United States, 21014
        • Steven Lenowitz, MD
      • Columbia, Maryland, United States, 21044
        • Kathryn Cervi
      • Galena, Maryland, United States, 21635
        • Elizabeth P Sipala
      • Prince Frederick, Maryland, United States, 20678
        • Deborah A. Davis, MSN, CRNP
    • Massachusetts
      • Gt. Barrington, Massachusetts, United States, 01230
        • Martha Klay
      • Springfield, Massachusetts, United States, 01107
        • Pioneer Valley Urology
      • Walpole, Massachusetts, United States, 02081
        • Margaret Duggan
    • Michigan
      • Dearborn, Michigan, United States, 48124
        • Kathryn Koches
      • Paw Paw, Michigan, United States, 49079
        • Women's Health Care Specialists, PC
      • Riverview, Michigan, United States, 48193
        • Isabel M Raposo
      • Saginaw, Michigan, United States, 48638
        • Laura Hintz
    • Mississippi
      • Jackson, Mississippi, United States, 39202
        • Mickie G. Autry PhD, NP-C
    • Montana
      • Kalispell, Montana, United States, 59901
        • Kathleen M. Young RNC NP
    • New Jersey
      • East Brunswick, New Jersey, United States, 08816
        • Urogynecology Arts of New Jersey
      • Galloway, New Jersey, United States, 08205
        • Lynda M. Adamson
      • Hamburg, New Jersey, United States, 07419
        • Women's Total Health
      • Vineland, New Jersey, United States, 08360
        • Cindy Nevara APN
    • New York
      • Albany, New York, United States, 12205
        • Jeanne Ann Dahl, RNC, WHNP
      • Cortland, New York, United States, 13045
        • Meredith Schledorn
      • Oswego, New York, United States, 13126
        • Raj Mahajan MD
      • W. Seneca, New York, United States, 14224
        • Diane Stonemetz
    • North Dakota
      • Minot, North Dakota, United States, 58703
        • Kathy Edwards
    • Ohio
      • Columbus, Ohio, United States, 43213
        • Columbus OB/Gyn Inc.
      • Columbus, Ohio, United States, 43213
        • Holly Murphy
      • Columbus, Ohio, United States, 43222
        • Susan Frost
      • Fairfield, Ohio, United States, 45014
        • Amy G Brenner M.D
      • Gallipolis, Ohio, United States, 45631
        • Elizabeth D. Allen CNP
    • Oklahoma
      • Tulsa, Oklahoma, United States, 74133
        • William Shuler, MD
    • Oregon
      • Bend, Oregon, United States, 97701
        • Deborah Malone
      • Eugene, Oregon, United States, 97401
        • Anne Marie Moore, Womens Health Nurse Practitioner
      • Portland, Oregon, United States, 97219
        • Cathleen Ann Folk FNP
      • Roseburg, Oregon, United States, 97470
        • Mary L Hagood, FNP-C
    • Pennsylvania
      • Allentown, Pennsylvania, United States, 18103
        • Institute for Female Pelvic Medicine
      • St. Mary's, Pennsylvania, United States, 15857
        • Paulette Schreiber, CRNP
      • West Chester, Pennsylvania, United States, 19380
        • Marie T Ziegler
    • South Carolina
      • Lexington, South Carolina, United States, 29072
        • Nancy Newman RNC, WHNP
    • Tennessee
      • Collierville, Tennessee, United States, 38017
        • Sharon Little
      • Franklin, Tennessee, United States, 37067
        • Margaret A. Hull
      • Nashville, Tennessee, United States, 37209
        • Urology Associates, P.C.
    • Texas
      • Arlington, Texas, United States, 76014
        • John Pickel MD
      • Houston, Texas, United States, 77030
        • Christopher J. Jayne, MD, FACOG
      • San Antonio, Texas, United States, 78229
        • Urology San Antonio
      • San Antonio, Texas, United States, 78232
        • Marney Kidwell RNC
      • Waco, Texas, United States, 76708
        • D. Crawford Allison MD
    • Utah
      • Lehi, Utah, United States, 84043
        • Laura C. Maw
    • Vermont
      • Bennington, Vermont, United States, 05201
        • Betsy Browning
    • Virginia
      • Chesapeake, Virginia, United States, 23320
        • Anne L Stephens
      • Chesapeake, Virginia, United States, 23320
        • Rand Gynecology, LLC
      • Lansdowne, Virginia, United States, 20176
        • Julie Spencer
      • Newport News, Virginia, United States, 23602
        • Patrice C Malena
    • Washington
      • Ilwaco, Washington, United States, 98624
        • Ocean Beach Women's Clinic
      • Vashon, Washington, United States, 98070
        • Kimberly Scheer
      • Christiansted, Virgin Islands (U.S.), 00820
        • Primary Care, PLLC

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  1. Women between the ages of 30 and 70 years
  2. Suffer from urge-incontinence, stress incontinence or incontinence of mixed etiology and who may benefit from strengthening Kegel muscles by electrical stimulation
  3. Able to provide informed consent and physically able to comply with protocol requirements.
  4. Experience one or more incontinence episodes per week.
  5. Women of childbearing potential must have a negative urine or blood pregnancy test within 7 days prior to initiation of treatment.
  6. Subject may be post-menopausal, surgically sterilized, or willing to use acceptable methods of birth control (e.g., hormonal contraceptive, intra- uterine device (IUD), diaphragm with spermicide, condom with spermicide or abstinence) from the screening visit through the duration of study participation.
  7. Have a positive response to two or more questions on the Athena Questionnaire

Exclusion Criteria:

  1. Neurological deficiency that does not permit proper sensory perception or stimulation.
  2. Is currently pregnant, lactating or attempting to get pregnant
  3. Has a cardiac pacemaker or a history of rate or conductive disturbance
  4. Has anatomical vaginal structures that do not permit proper and complete placement of the trainer.
  5. Has irregular menstrual bleeding cycles.
  6. Has urinary or vaginal infections, localized lesions, or other undiagnosed symptoms.
  7. Has a history or symptoms of urinary retention.
  8. Has cancer or a life expectancy of less than one year
  9. Recreational drug use
  10. Consume more than three caffeine beverages daily
  11. Consume more than 1-2 alcoholic drinks per day
  12. Significant drug use (causing diuresis or urinary retention
  13. Allergy or sensitivity to materials in the Athena PMT
  14. Participation in another clinical trial within past 3 months
  15. Subjects morbidly obese (BMI >35)
  16. Subjects who chronically smoke (> 10 cigarettes per day)
  17. Subjects required to do heavy lifting (> 40 pounds regularly)
  18. Surgery within the past six months for incontinence, or use of other incontinence devices
  19. Currently taking cholinergic or anti-cholinergic drugs or other prescription or non-prescription drugs that may increase or decrease the volume or frequency of urination and thus, may confound the results of this study, except, in the opinion of the investigator. The subject's regimen has been stable for at least sixty days.
  20. Suspected infection or condition (e.g., diabetes) that would alter the subjects ability to participate or would confound the results of the trial

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To assess objective treatment outcomes of urge, stress or mixed incontinence.
Time Frame: 5 Visits over 13 weeks. Subjects are seen in the office at Screening Visit 1 (Week -1), Visit 1a (Week 0), Visit 2 (Week 2), Visit 3 (Week 6), Visit 4 (Week 12)
Outcomes will be measured via patient questionnaires over a 13 week trial. Visit 1 (Week -1) and Visit 4 (Week 12) values for the Overactive Bladder Questionnaire and the Female Sexual Function Index will be captured. 7-day Urine Diaries will be captured for the week preceeding visits 2, 3 and 4.
5 Visits over 13 weeks. Subjects are seen in the office at Screening Visit 1 (Week -1), Visit 1a (Week 0), Visit 2 (Week 2), Visit 3 (Week 6), Visit 4 (Week 12)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluate effectiveness, tolerability, satisfaction and compliance of the Athena PMT across a wide demographic population using: 1) the Subject Satisfaction Evaluation questionnaire
Time Frame: At Visit 4 (Week 12)
At the last visit, patients will complete a Subject Satisfaction Survey.
At Visit 4 (Week 12)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Julia Shaw, MD, Director of Women's Health, Yale University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2010

Primary Completion (Actual)

June 1, 2011

Study Completion (Actual)

June 1, 2011

Study Registration Dates

First Submitted

February 17, 2010

First Submitted That Met QC Criteria

February 22, 2010

First Posted (Estimate)

February 23, 2010

Study Record Updates

Last Update Posted (Estimate)

July 14, 2011

Last Update Submitted That Met QC Criteria

July 13, 2011

Last Verified

July 1, 2011

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Urinary Incontinence

Clinical Trials on Athena Pelvic Muscle Trainer

3
Subscribe